From: Asia Times
December 20, 2006 11:41 Beijing Time
Font Size:       Email Email to Friends   Comment Comment (0)
 
As global pharmaceutical companies grapple with the high cost of research and development (R&D), attention is beginning to shift toward China as a potential hub for innovation in biotechnology.

>> Full Article

Previous: Unique Species of Dolphin Might Be Extinct, Due to Pollution